Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors

Molecular Pharmacology

Volumn 65, Issue 6, 2004, Pages 1386-1396

  Kloda, Anna ^a   Clements, John D ^b   Lewis, Richard J ^a   Adams, David J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYTIDINE TRIPHOSPHATE; GLUTAMIC ACID; GUANOSINE TRIPHOSPHATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; PURINE P2X RECEPTOR; URIDINE TRIPHOSPHATE;

AGONIST; ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING SITE; CHANNEL GATING; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC FIELD; EVOKED RESPONSE; FEMALE; HIPPOCAMPUS; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; XENOPUS LAEVIS;

ADENOSINE TRIPHOSPHATE; ALLOSTERIC REGULATION; ANIMALS; BINDING SITES; CHELATING AGENTS; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; METALS, HEAVY; OOCYTES; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; XENOPUS LAEVIS;

EID: 2442702848     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.6.1386     Document Type: Article

References (40)

1. Baron BM, Dudley MW, McCarty DR, Miller FP, Reynolds IJ, and Schmidt CJ (1989) Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo. J Pharmacol Exp Ther 250:162-169.
2. Bennett GJ (2000) Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage 19:S2-S6.
3. Benveniste M and Mayer ML (1991) Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Biophys J 59:560-573.
4. Bliss TV and Collingridge GL (1993) A synaptic model of memory: long term potentiation in the hippocampus. Nature (Lond) 361:31-39.
5. Castellano C, Cestari V, and Ciamei A (2001) NMDA receptors in learning and memory processes. Curr Drug Targets 2:273-283.
6. Chapman AG (1998) Glutamate receptors in epilepsy. Prog Brain Res 116:371-383.
7. Choi DW (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal cell death. Annu Rev Neurosci 13:171-182.
8. Clements JD (1996) Transmitter time course in the synaptic cleft: its role in central synaptic function. Trends Neurosci 19:163-171.
9. Clements JD, Lester RAJ, Tong G, Jahr CE, and Westbrook GL (1992) The time course of glutamate in the synaptic cleft. Science (Wash DC) 258:1498-1501.
10. Clements JD and Westbrook GL (1991) Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-D-aspartate receptor. Neuron 7:605-613.
11. Clements JD and Westbrook GL (1994) Kinetics of AP5 dissociation from NMDA receptors: evidence for two identical cooperative binding sites. J Neurophysiol 71:2566-2569.
12. DiCori S and Henry JL (1984) Effects of ATP and AMP on hippocampal neurones of the rat in vitro. Brain Res Bull 13:199-201.
13. Dingledine R, McBain CJ, and McNamara JO (1990) Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci 11:334-338.
14. Dunwiddie TV and Hoffer BJ (1980) Adenine nucleotides and synaptic transmission in the in vitro rat hippocampus. Br J Pharmacol 69:59-68.
15. Edwards FA, Gibb AJ, and Colquhoun D (1992) ATP receptor-mediated synaptic currents in central nervous system. Nature (Lond) 359:144-147.
16. Fujii S, Kato H, and Kuroda Y (2002) Cooperativity between extracellular adenosine 5′-triphosphate and activation of N-methyl-D-aspartate receptors in long-term potentiation induction in hippocampal CA1 neurons. Neuroscience 113:617-628.
17. Gu JG and MacDermott AB (1997) Activation of ATP P2X receptors elicits glutamate release from sensory neurone synapses. Nature (Lond) 389:749-753.
18. Hamann M and Attwell D (1996) Non-synaptic release of ATP by electrical stimulation in slices of rat hippocampus, cerebellum and habenula. Eur J Neurosci 8:1510-1515.
19. Hirai H, Kirsch J, Laube B, Betz H, and Kuhse J (1996) The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region. Proc Natl Acad Sci (USA) 93:6031-6036.
20. Kauer JM, Malenka RC, and Nicoll RA (1988) NMDA application potentiates synaptic transmission in the hippocampus. Nature (Lond) 334:250-252.
21. Khakh BS, Zhou X, Sydes J, Galligan JJ, and Lester HA (2000) State-dependent cross-inhibition between transmitter-gated cation channels. Nature (Lond) 406:405-410.
22. Kleckner NW, Glazewski JC, Chen CC, and Moscrip TD (1999) Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action. J Pharmacol Exp Ther 289:886-894.
23. Laube B, Hirai H, Sturgess M, Betz H, and Kuhse J (1997) Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 18:493-505.
24. Laube B, Kuhse J, and Betz H (1998) Evidence for a tetrameric structure of recombinant NMDA receptors. J Neurosci 18:2954-2961.
25. Mayer ML, Benveniste M, Patneau DK, and Vyklicky L (1992) Pharmacologic properties of NMDA receptors. Ann NY Acad Sci 648:194-204.
26. McBain CJ and Mayer ML (1994) N-methyl-D-aspartic acid receptor structure and function. Physiol Rev 74:723-759.
27. Monahan JB, Hood WF, Michel J, and Compton RP (1988) Effects of guanine nucleotides on N-methyl-D-aspartate receptor-ligand interactions. Mol Pharmacol 34:111-116.
28. Mori M, Heuss C, Gahwiler BH, and Gerber U (2001) Fast synaptic transmission mediated by P2X receptors in CA3 pyramidal cells of rat hippocampal slice cultures. J Physiol (Lond) 535:115-123.
29. Motin L and Bennett MR (1995) Effect of P2-purinoceptor antagonists on glutamatergic transmission in the rat hippocampus. Br J Pharmacol 115:1276-1280.
30. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067.
31. Olney JW (1990) Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicol 30:47-71.
32. Ortinau S, Laube B, and Zimmermann H (2003) ATP inhibits NMDA receptors after heterologous expression and in cultured hippocampal neurons and attenuates NMDA-mediated neurotoxicity. J Neurosci 23:4996-5003.
33. Paoletti P, Ascher P, and Neyton J (1997) High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 17:5711-5725.
34. Pancratov YV, Lalo UV, and Krishtal OA (2002) Role for P2X receptors in long-term potentiation. J Neurosci 22:8363-8369.
35. Sillen LG and Martell AE (1971) Stability constants of metal-ion complexes. Suppl. 1, special publication 25, The Chemical Society, London.
36. Singer W (1995) Development and plasticity of cortical processing architectures. Science (Wash DC) 270:758-764.
37. Wieraszko A and Ehrlich YH (1994) On the role of extracellular ATP in the induction of long-term potentiation in the hippocampus. J Neurochem 63:1731-1738.
38. Wieraszko A, Goldsmith G, and Seyfried TN (1989) Stimulation-dependent release of adenosine triphosphate from hippocampal slices. Brain Res 485:244-250.
39. Wieraszko A and Seyfried TN (1989) ATP-induced synaptic potentiation in hippocampal slices. Brain Res 491:356-359.
40. Zimmermann H (1994) Signaling via ATP in the nervous system. Trends Neurosci 17:420-426.